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Alveolar bone repair with strontium-
containing nanostructured carbonated 
hydroxyapatite
Objective: This study aimed to evaluate bone repair in rat dental 
sockets after implanting nanostructured carbonated hydroxyapatite/sodium 
alginate (CHA) and nanostructured carbonated hydroxyapatite/sodium 
alginate containing 5% strontium microspheres (SrCHA) as bone substitute 
materials. Methods: Twenty male Wistar rats were randomly divided into two 
experimental groups: CHA and SrCHA (n=5/period/group). After one and 
6 weeks of extraction of the right maxillary central incisor and biomaterial 
implantation, 5 µm bone blocks were obtained for histomorphometric 
evaluation. The parameters evaluated were remaining biomaterial, loose 
connective tissue and newly formed bone in a standard area. Statistical 
analysis was performed by Mann-Withney and and Wilcoxon tests at 95% 
level of significance. Results: The histomorphometric results showed that the 
microspheres showed similar fragmentation and bio-absorbation (p>0.05). 
We observed the formation of new bones in both groups during the same 
experimental periods; however, the new bone formation  differed significantly 
between the weeks 1 and 6 (p=0.0039) in both groups. Conclusion: The 
CHA and SrCHA biomaterials were biocompatible, osteoconductive and 
bioabsorbable, indicating their great potential for clinical use as bone 
substitutes.
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Introduction
Implant-supported restoration has been increasingly 
performed by dentists for both aesthetic and functional 
reasons. However, when infections, pathological 
processes, extractions, or congenital and traumatic 
injuries on the maxilla and the mandible lead to bone 
loss, dental implant installation might not be the best 
opition20. Therefore, to minimize the loss of alveolar 
bone, or even restore it, different types of alloplastic 
grafts have been used, and new biomaterials have 
been the focus of research aiming to develop bone 
substitutes.
Among these grafts, HA Ca10(PO4)6(OH)2 has been 
widely used as a bone substitute for approximately 
80 years18.  This ceramic is biocompatible, 
osteoconductive15, similar to the bone and tooth tissue 
inorganic portions1, bioactive, and allows substitutions 
in its molecular formula and periodic monitoring via 
imaging because of its radiopacity. Additionally, it 
is mechanically tough and bioactive, and it is not 
antigenic, carcinogenic, or toxic.
However, the clinically used HA is not biodegradable 
and remains at the implantation site for long periods23, 
which limits bone regeneration. The lack of degradation 
is probably due to the high temperatures during 
ceramics production16 and treatment after synthesis 
(sintering), which increases the crystallinity and 
hinders biosorption. With this in mind, nanostructured 
materials composed of particles smaller than 100 nm 
with low crystallinity show to  be potential alternatives 
to grafts when produced with non-sintered materials 
at low temperatures17, considering they can imitate 
biological apatite12.
Researchers have chemically modified HA by 
substituting phosphate groups (PO4) or hydroxyl 
groups (OH) with carbonate (CO3) to develop a 
nanostructured carbonated hydroxyapatite at low 
temperatures9. Under these conditions, the produced 
biomaterial is similar to stoichiometric HA, but with 
lower crystallinity and higher solubility, which favors 
rapid bioabsorption and bone regeneration17.
Furthermore, the stability and flexibility of the 
HA structure enables different ionic substitutions3. 
It is possible to induce the exchange of many 
cations and anions by modifying the structure of 
stoichiometric HA to resemble biological apatite1. 
In these techniques, calcium frequently substitutes 
strontium (Sr2+)10; despite still being present in lower 
amounts compared to strontium, calcium alters the 
crystal structure and some HA properties, including 
phase stability, solubility, and reactivity4, thus 
decreasing ceramic mechanical strength. Additionally, 
strontium reduces bone resorption and increases bone 
formation. The high solubility of HA combined with 
Sr2+ increases the number of interconnected pores, 
promoting cell migration, interfacial bonding13, and 
osseointegration11,18.
Thus, this study evaluated histomorphometric bone 
repair in rat tooth sockets after implanting CHA and 
SrCHA synthesized at low temperatures.
Material and methods
Animal experiments and breeding were performed 
according to the institutional review board (CEUA/
UFF), N°179/2012, the NIH Guide for Care and Use 
of Laboratory Animals and the Brazilian legislation on 
animal research.
Biomaterials
The nanostructured carbonated hydroxyapatite 
powder and nanostructured carbonated hydroxyapatite 
containing strontium were prepared using a 
precipitation wet method with average temperature 
of 5°C and 6% wt CO3. The synthesized solids were 
filtered and washed with deionized water (MilliQ®, 
Millipore Corporation, Billerica, MA, USA) until reaching 
neutral pH (pH=7). Then, the material was lyophilized 
in a FreeZone 1 lyophilizer (Labconco®, Kansas City, 
Missouri, USA) and separated on sieves according to 
particle sizes from 74 μm to 37 μm.
To produce microspheres, the obtained powders 
were individually mixed with a solution of sodium 
alginate (Sigma Aldric®/Fluka Biochemika®, Buchs, 
Switzerland) diluted in ultrapure water (MilliQ®, 
Millipore Corporation, Billerica, MA, USA) at a ratio of 
15:1. The mixture was then extruded into 0.15 molar 
calcium chloride (0.15 M CaCl2), in which instant 
microsphere formation was observed. The mixture was 
kept at rest for 24 h until complete gelation. After this 
step, the microspheres were washed with ultrapure 
water until fully eliminating saline. Immediately 
after the washing, the microspheres were dried by 
lyophilization for 24 h and separated on a stainless 
steel sieve with a particle size from 425 μm to 600 μm. 
The microspheres were then separated into aliquots in 
Alveolar bone repair with strontium-containing nanostructured carbonated hydroxyapatite
J Appl Oral Sci. 2018;26:e201700843/9
an Eppendorf tube and sterilized with gamma radiation 
in a cobalt-60 irradiator (Gamma Cell) for 760 m with 
total dose of 15 kGy and dose rate of 19.72 Gy/m. 
Electron microscopy scanning of the microspheres 
showed similar morphology and surface texture. 
SrCHA presented fewer surface pores than CHA, as 
previously shown25.
The XRD patterns revealed that the microspheres 
had low crystallinity, as indicated by the broad and 
poorly defined peaks. However, the XRD pattern of 
SrCHA (Figure 1) showed narrower peaks than that 
of CHA because of the presence of Sr.
The spectra in Figure 2 show the vibrational bands 
correspond to CHA. The 3435 and 1639 cm−1 regions, 
which are large and intense, represent water bands, 
indicating that the material is not ceramic. In Figure 
2, regions 867, 868, 1415, 1425 and 1482 cm−1 show 
carbonate ions, indicating that replacement occurred 
as expected. The other bands that can be observed in 
the figure show phosphate ions. Because of the high 
hydration of the samples, it was not possible to identify 
hydroxyl ions representative bands.
Animals and surgical procedure
A total of 20 male Wistar rats with average weight 
of 300 g were randomly divided into two groups (CHA 
and SrCHA) with five animals for each experimental 
period. The sample size was based previous studies 
that followed the same animal protocol16. According 
to the CONCEA and 3R’s program, we should reduce 
the number of animals in experimentation as much as 
possible without loosing the accuracy of the statistical 
analysis. Five animals for each group is the minimum 
to perform the normality test21. The animals were 
evaluated after one and six weeks.
After anesthesia with intramuscular injection of 75 
Figure 1- XRD pattern of CHA and SrCHA. The peaks of SrCHA are narrower than those of CHA, indicating low cristallinity for SrCHA 
when compared to the CHA group
Figure 2- Infrared Fourier transform spectrum of CHA and SrCHA. We observed major bands regarding phosphate and carbonate groups, 
a characteristic of carbonated hydroxyapatite. Presence of water bands, indicating the material is not ceramic (regions 867, 868, 1415, 
1425, and 1482 cm−1)
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mg/kg ketamine hydrochloride (Ketalar®, Veltbrands, 
São Paulo, Brazil) and sedation with 1.5 ml/kg 
xylazine (Rompun®, Veltbrands, São Paulo, Brazil), 
the antisepsis of the perioral region and oral mucosa 
was achieved with 2.0% and 0.12% chlorhexidine, 
respectively. Then, sindesmotomy and extraction of 
the upper right central incisor were performed with a 
dental explorer no. 5 (Duflex®, São Paulo, SP, Brazil) 
and a pediatric forceps no. 151 (Duflex®, São Paulo, SP, 
Brazil), respectively (Figure 3A and 3B), and 0.2 mg 
of the biomaterials (Figure 3C) was implanted in the 
tooth socket, followed by suturing (Figure 3D). After 
the surgical procedures were completed, postoperative 
analgesia with 1 mg/kg meloxicam (Duprat®, Rio de 
Janeiro, Brazil) was administered subcutaneously 
every 24 h for three d since  the day of the surgery.
After the experimental period, the animals were 
euthanized by applying a lethal dose of thiopental 
150 mg/kg [(Thiopentax® (Cristália), Itapira, São 
Paulo, Brazil)] to collect bone blocks containing the 
biomaterials and surrounding tissues. The specimens 
were fixed in 4% formaldehyde, decalcified in 
decalcification solution (Allkimia®, Campinas, São 
Paulo, Brazil) for 48 h and embedded in paraffin. 
The blocks were cut at 5-μm thickness, stained with 
hematoxylin and eosin (HE) and examined by light 
microscopy (Eclipse E400, Nikon®, Tokyo, Japan).
Histomorphometric analysis
Histomorphometric analysis was performed to 
quantify the remaining biomaterial, the  connective 
tissue loose and the bone newly formed in the 
standard area. The morphometric measurements were 
performed using the Image-Pro Plus® software, version 
4.5.0.29 (Media Cybernetics, Silver Spring, EUA) with 
5 microscopic fields under 20x augmentation with a 
1-blinded examiner (SCS). In each histological slice 
stained with HE, 5 non-superimposing microscopic 
fields obtained by scanning at 20x magnification were 
captured in the medium third region of the socket 
Figure 3- Representative photomicrographs of alveolar socket after 7 days. A and B: CHA group and C and D: SrCHA group. In A and B: 
presence of connective tissue surrounding the biomaterial (BM) microsphere and peripheric newly formed bone (NFB). C and D: presence 
of newly formed bone surrounding the connective tissue area, containing particulate biomaterial with peripheric osteoid (#).
Square with 40-fold magnification taken from A and C, respectively. NFB: Newly Formed Bone; BM: Biomaterial; CT: Connective Tissue; 
#: Osteoid. Hematoxylin and eosin stained. Bar: A and C: 100 µm; B and D: 50 µm
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after biomaterial implantation. With the Image-Pro 
Plus® 6.0 (Media Cybernetics, Silver Spring, Maryland, 
USA), a grid of 250 points superimposed on the area 
under analysis allowed the determination of the 
volume density of the newly formed bone, of the 
connective tissue and of the residual biomaterial. The 
250 points superimposed on each photomicrograph 
were considered as 100%, so each point was classified 
and the percentage of each parameter was obtained.
Statistical analysis
The results are presented as percentages, and 
values are presented as the mean value (±) standard 
deviation. The mean values and standard deviations 
obtained in each group were tested for normality 
according to D’Agostino-Pearson’s omnibus test. The 
data did not present a normal distribution, this way 
both the non-parametric statistical analysis of Mann-
Withney for inter-group and and the Wilcoxon for intra-
group were performed using the Prism Graph Pad 6.3 
software (Inc. La Jolla, California, USA), with p≤0.05 




At the first experiment, both biomaterial groups 
presented the dental socket filled with fragmented 
biomaterial spheres surrounded by granulation tissue 
with remnants of blood clots, neoformed capillaries, 
and fibroblasts. In both groups, we observed moderate 
mononuclear inflammatory infiltrate as lymphocytes 
and macrophages between the components of the 
conjunctive tissue and the surroundings of partially 
bioabsorbed microspheres. We also observed giant 
cells permeating the biomaterial particles. New bone 
formation occurred centripetally in patches during this 
period and was more evident in the apical region of 
Figure 4- Representative photomicrographs of alveolar socket after 42 days. A and B: CHA group and C and D: SrCHA group. A and 
B: observe the presence of newly formed bone (NFB) with osteocytes (arrow) and osteoblastic paving (*) permeated by fibrocellular 
connective tissue (CT), with few inflammatory cells and absence of biomaterial (BM). C and D: presence of new-formed bone with 
connective tissue at the surroundings containing fragmented biomaterial and peripheric osteoid (#). A and C: 20-fold magnification and B 
and D: square with 40-fold magnification taken from A and C, respectively. BM: Biomaterial, NFB: Newly Formed Bone, CT: Connective 
Tissue; #: Osteoid, *: Osteoblasts. Hematoxylin and eosin stained. Bar: A and C: 100 µm; B and D: 50 µm
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the socket (Figure 3). 
6 weeks
In both groups, we observed a discrete chronic 
inflammatory response, with a few giant cells close to 
the microspheres, which were evidently fragmented. 
The biomaterials were fragmented and bioabsorbed 
differently. The quantity of remaining material in the 
SrCHA group was slightly lower than that from the 
CHA group. Bone formation process replaced the 
inflammatory cell content in the first experiment at 
the same time that there was a decrease in mature 
connective tissue composed by collagen fibers. 
The newly formed bone characterized by the thick 
trabecular bone was similar in both groups and 
occurred near the remaining bone and in direct contact 
with microspheres (Figure 4). 
The histological evaluation showed that in the 
interstitial spaces formed between the microspheres 
with no bone formation had a highly vascularized 
loose of connective tissue after one week that showed 
increased organization after six weeks with newly 
formed bone. This angiogenesis is essential for bone 
regeneration because these new blood vessels provide 
oxygen, nutrients, and cells, all considered essential 
for bone formation.
Histomorphometric evaluation
Histomorphometr ic  analys is  showed no 
significant differences after 1 (CHA=14.6±2.50 and 
SrCHA=18.9±1.69) and 6 weeks (CHA=16.5±2.41 
and SrCHA=10.4±2.33) between groups regarding 
biomaterials bioabsorption (Figure 5). The amount 
of connective tissue formed in the tooth socket 
permeating the microspheres was similar for both 
Figure 5- Volume density of the remaining biomaterial in the dental alveolus after 1 and 6 weeks of implantation. The values were 
similar for both groups in both experimental periods. We observed no significant difference between groups. Results are shown as mean 
percentages ± confidence intervals (vertical bars)
Figure 6- Volume density of connective tissue in the tooth socket after 1 and 6 weeks of implantation. The values were similar for both 
groups in both experimental periods. We observed no significant difference between groups. Results are shown as mean percentages ± 
confidence interval (vertical bars)
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groups and periods (Figure 6). Regarding the newly 
formed bone, morphometric analysis showed that the 
percentage of mineralized tissue was similar between 
groups at 1 (CHA=18.2±2.04 and SrCHA=17±17, 
and 6 weeks (CHA=28.2±3.82 and SrCHA=32±4.15). 
However, we observed a higher percentage of newly 
formed bone in both groups after 6 weeks when 
compared to1 week (p=0.0039) (Figure 7).
Discussion
Calcium ions in biological apatite have been 
partially substituted with other ions, such as Sr2+, 
Mg2+, and Zn2+. This change affects the crystallinity, 
solubility, surface energy, and dissolution rate of the 
material, thus improving its bioactivity. Based on 
these findings, this study evaluated a promising bone 
substitute based on a synthesized at low temperature 
nanostructured carbonated hydroxyapatite containing 
strontium10.
According to a previous study5, the sintering 
of nanostructured hydroxyapatite causes crystal 
densification and nanostructured features loss, thereby 
increasing crystallinity and reducing solubility15. 
Additionally, the sintering process is responsible for 
the removal of sodium alginate. In this study, we did 
not sintered the materials, retaining their nanometric 
characteristics, low crystallinity and sodium alginate 
content.
The non-strontium-containing hydroxyapatite 
was used as control group, as we aimed to evaluate 
the influence of strontium on hydroxyapatite in bone 
repair. We did not perform the dental socket filling 
with blood clot, as these results have already been 
published with the same experimental periods22 and 
are already established in the literature19. In addition, 
according to the recommendation by the CONCEA and 
the 3R’s Program21, the number of animals used in 
experimental studies should be reduced.
The biomaterials evaluated in this study were 
biocompatible, despite the presence of a limited 
chronic inflammatory response with giant cells that 
diminished with time. The giant cells, considered 
as foreign body type giant cells, are of monocytic-
phagocytic lineage and are important in the tissue 
repair mechanism, as they carry out cellular and 
tissue debris phagocytose, as well as contribute to 
the bioabsorption of  biomaterial fragments, besides 
secreting cytokines that favor essential cellular events 
in tissue repair. The presence of multinucleated 
giant cells modulated by the chemical surface of 
the biomaterials2 has demonstrated the importance 
of macrophage subsets in the reaction to foreign 
bodies and, consequently, in the biocompatibility of 
biomaterials6,7. Therefore, the presence of these cells 
can occur as an attempt to reabsorb the material, 
which not necessarily implies lack of biocompatibility. 
From a biological point of view, the material 
fragmentation caused by lower crystallinity and smaller 
particles susceptible to phagocytosis could justify the 
presence of these cells around the particles. This type 
of tissue response is considered inherent to the healing 
mechanism after the implantation of biomaterials14 
and has been observed in other studies on bone 
regeneration with biomaterials14. 
Figure 7- Volume density of newly formed bone. The quantity of newly formed mineralized tissue was similar in both groups in both 
experimental periods. However, we observed more newly formed bone at 6 weeks than at 1 week. The horizontal lines between bars 
indicate significant differences between groups (p<0.05). Results are shown as mean percentages ± confidence interval (vertical bars)
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A previous study observed that at the nanoscale, 
the biomaterial resembled biological apatite5 and 
presented bioabsorption similar to that observed in 
other studies15,19. Such bioabsorption is an essential 
for a suitable bone substitute because biosorption 
is important for bone physiology after biomaterial 
implantation15. In areas where the microspheres 
were bioabsorbed, we observed the formation of 
mineralized tissue, characterized by more cellular 
and non-lamellar bone associated with microspheres 
and at contact with the remaining alveolar bone, 
delimiting the dental alveolus, which confirms that 
the nanostructured carbonated HA here evaluated was 
bioactive, osteoconductive16,19 and highly crystalline5,23.
The use of biomaterial microspheres has been 
considered preferable because the interstitial space 
between the implanted spheres provides macropores 
for tissue invasion and also because microsphere 
implantation can be performed with minimally invasive 
surgical techniques. In addition, the spheres do not 
have surface edges or dimensions that could lead to 
inflammation. To produce the microspheres, we mixed 
nanostructured carbonated HA powders with sodium 
alginate, an inert and biodegradable polymer. The 
histological results showed that there were interstitial 
spaces between the microspheres. In areas where 
there was no new bone formation, we observed a 
highly vascularized and loose connective tissue after 
one week that showed increased organization after 
six weeks. This angiogenesis is essential for bone 
regeneration because these new blood vessels provide 
oxygen, nutrients, and cells considered essential for 
bone formation24.
In the histological evaluation, we observed a 
greater fragmentation of SrCHA compared to the 
CHA group. We did not sinter the biomaterials used 
in this study, so they are considered low crystalline 
materials. However, the incorporation of strontium in 
the hydroxyapatite by partially replacing it with calcium 
changed crystallinity, morphology, lattice parameters, 
crystal size, stability, bioactivity, biocompatibility, 
and osteoconductivity of CHA. This set of physical 
and chemical changes alter the fragmentation and 
bioabsorption of biomaterials25.
Sr2+ has been widely used for partial substitutions 
of HA because of its dual ability to stimulate bone 
formation and reduce bone resorption. However, in 
our study, we observed no increase in newly formed 
mineralized tissue in the SrCHA group, indicating 
that Sr2+ did not influence the osteogenic potential 
of nanostructured carbonated HA, possibly because 
of the low Sr2+ content (1.7%) identified by atomic 
absorption spectrometry after synthesis and prior to 
the implantation, regardless of an initial theoretical 
Sr2+ concentration of 5%. These results are similar to 
those obtained by other study8 aimed at producing 
1% ZnHA, obtaining a maximum incorporation of 
0.4%. Similarly, Resende, et al.23 (2013) showed a 
reduction of approximately 50% in the experimental 
zinc concentration of ZnHA compared to the initial 
theoretical concentration.
Conclusion
Our results suggest that both CHA and SrCHA, 
produced at low temperature and not sintered, 
were biocompatible, bioactive, ostecondutive 
osteoconductive, and bioabsorbable, indicating its 
great potential for clinical use as bone substitutes. 
Further studies with a higher content of Sr2+ associated 
with nanostructured carbonated hydroxyapatite 
are necessary to evaluate the effect of Sr2+ on the 
biological response. 
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